Organogenesis Holdings Statistics
Total Valuation
ORGO has a market cap or net worth of $384.46 million. The enterprise value is $411.33 million.
| Market Cap | 384.46M |
| Enterprise Value | 411.33M |
Important Dates
The next confirmed earnings date is Thursday, August 8, 2024, after market close.
| Earnings Date | Aug 8, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ORGO has 132.57 million shares outstanding. The number of shares has increased by 0.59% in one year.
| Shares Outstanding | 132.57M |
| Shares Change (YoY) | +0.59% |
| Shares Change (QoQ) | -0.57% |
| Owned by Insiders (%) | 32.88% |
| Owned by Institutions (%) | 45.91% |
| Float | 61.84M |
Valuation Ratios
The trailing PE ratio is 72.50 and the forward PE ratio is 12.32.
| PE Ratio | 72.50 |
| Forward PE | 12.32 |
| PS Ratio | 0.88 |
| Forward PS | 0.80 |
| PB Ratio | 1.38 |
| P/FCF Ratio | 56.47 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.27, with an EV/FCF ratio of 60.42.
| EV / Earnings | 70.74 |
| EV / Sales | 0.94 |
| EV / EBITDA | 11.27 |
| EV / EBIT | 32.31 |
| EV / FCF | 60.42 |
Financial Position
The company has a current ratio of 2.74, with a Debt / Equity ratio of 0.42.
| Current Ratio | 2.74 |
| Quick Ratio | 2.24 |
| Debt / Equity | 0.42 |
| Debt / EBITDA | 3.18 |
| Debt / FCF | 17.07 |
| Interest Coverage | 6.20 |
Financial Efficiency
Return on equity (ROE) is 2.10% and return on invested capital (ROIC) is 1.75%.
| Return on Equity (ROE) | 2.10% |
| Return on Assets (ROA) | 1.30% |
| Return on Capital (ROIC) | 1.75% |
| Revenue Per Employee | $505,190 |
| Profits Per Employee | $6,746 |
| Employee Count | 862 |
| Asset Turnover | 0.95 |
| Inventory Turnover | 4.08 |
Taxes
In the past 12 months, ORGO has paid $4.86 million in taxes.
| Income Tax | 4.86M |
| Effective Tax Rate | 45.54% |
Stock Price Statistics
The stock price has decreased by -34.54% in the last 52 weeks. The beta is 1.65, so ORGO's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | -34.54% |
| 50-Day Moving Average | 2.72 |
| 200-Day Moving Average | 2.95 |
| Relative Strength Index (RSI) | 55.49 |
| Average Volume (20 Days) | 1,042,984 |
Short Selling Information
The latest short interest is 11.33 million, so 8.55% of the outstanding shares have been sold short.
| Short Interest | 11.33M |
| Short Previous Month | 10.92M |
| Short % of Shares Out | 8.55% |
| Short % of Float | 18.32% |
| Short Ratio (days to cover) | 8.94 |
Income Statement
In the last 12 months, ORGO had revenue of $435.47 million and earned $5.82 million in profits. Earnings per share was $0.04.
| Revenue | 435.47M |
| Gross Profit | 326.90M |
| Operating Income | 12.67M |
| Pretax Income | 10.68M |
| Net Income | 5.82M |
| EBITDA | 36.49M |
| EBIT | 12.73M |
| Earnings Per Share (EPS) | $0.04 |
Balance Sheet
The company has $89.35 million in cash and $116.22 million in debt, giving a net cash position of -$26.87 million or -$0.20 per share.
| Cash & Cash Equivalents | 89.35M |
| Total Debt | 116.22M |
| Net Cash | -26.87M |
| Net Cash Per Share | -$0.20 |
| Equity (Book Value) | 278.03M |
| Book Value Per Share | 2.10 |
| Working Capital | 144.37M |
Cash Flow
In the last 12 months, operating cash flow was $25.83 million and capital expenditures -$19.02 million, giving a free cash flow of $6.81 million.
| Operating Cash Flow | 25.83M |
| Capital Expenditures | -19.02M |
| Free Cash Flow | 6.81M |
| FCF Per Share | $0.05 |
Margins
Gross margin is 75.07%, with operating and profit margins of 2.91% and 1.34%.
| Gross Margin | 75.07% |
| Operating Margin | 2.91% |
| Pretax Margin | 2.45% |
| Profit Margin | 1.34% |
| EBITDA Margin | 8.38% |
| EBIT Margin | 2.92% |
| FCF Margin | 1.56% |
Dividends & Yields
ORGO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.59% |
| Shareholder Yield | -0.59% |
| Earnings Yield | 1.51% |
| FCF Yield | 1.77% |
Analyst Forecast
The average price target for ORGO is $4.88, which is 68.28% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.88 |
| Price Target Difference | 68.28% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ORGO has an Altman Z-Score of 2.57 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.57 |
| Piotroski F-Score | 5 |